| Price | 4.9675 on 06-02-2026 at 19:20:03 |
|---|---|
| Change | 0.00 0% |
| Buy | 0.00 |
| Sell | 0.00 |
| Last Trade: | Unknown 540.00 at 4.9675 |
| Day's Volume: | 57,570 |
| Last Close: | 4.9675 |
| Open: | 0.00 |
| ISIN: | SE0003815604 |
| Day's Range | 0.00 - 0.00 |
| 52wk Range: | 3.13 - 6.55 |
| Market Capitalisation: | - |
| VWAP: | 4.977524 |
| Shares in Issue: | 395.16m |
Egetis Therapeu (0ABW) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 540 | 4.9675 | SI Trade |
14:25:56 - 06-Feb-26 |
| Unknown* | 604 | 4.9525 | SI Trade |
12:27:27 - 06-Feb-26 |
| Unknown* | 604 | 4.9525 | SI Trade |
12:27:27 - 06-Feb-26 |
| Unknown* | 1,388 | 4.95 | SI Trade |
12:27:23 - 06-Feb-26 |
| Unknown* | 1,388 | 4.95 | SI Trade |
12:27:23 - 06-Feb-26 |
| Unknown* | 23,000 | 4.985 | SI Trade |
12:24:37 - 06-Feb-26 |
| Unknown* | 24,000 | 4.98 | SI Trade |
09:25:14 - 06-Feb-26 |
| Unknown* | 5,000 | 4.95 | SI Trade |
09:17:30 - 06-Feb-26 |
| Unknown* | 523 | 4.995 | SI Trade |
08:56:18 - 06-Feb-26 |
| Unknown* | 523 | 4.995 | SI Trade |
08:56:18 - 06-Feb-26 |
Egetis Therapeu (0ABW) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Jan 2026 6:00 am | MFN | Egetis Completes the U.S. Rolling NDA Submission for Emcitate® (tiratricol) for Treatment of MCT8 Deficiency |
| 30th Dec 2025 7:00 am | MFN | Change in the number of ordinary shares and votes in Egetis Therapeutics |
| 19th Dec 2025 6:00 am | RNS | Egetis Therapeutics initiates New Drug Application in the USA for Emcitate® (tiratricol) for MCT8 deficiency |
| 19th Dec 2025 6:00 am | MFN | Egetis Therapeutics initiates New Drug Application in the USA for Emcitate® (tiratricol) for MCT8 deficiency |
| 25th Nov 2025 6:00 am | MFN | Interim report Q3 2025 |
| 14th Nov 2025 6:00 am | MFN | Egetis announces positive results from the ReTRIACt study of Emcitate® (tiratricol) in MCT8 deficiency |
